PharmTech Europe News

Lonza, IBF Collaborate to Support Development and Manufacturing of Biologics and Small Molecules

May 26, 2022

Lonza and Israel Biotech Fund form a two-year agreement to support accelerated development and manufacture of biologics and small molecules.

Vaxzevria Gains Approval in EU as a Third Dose COVID-19 Booster in Adults

May 24, 2022

AstraZeneca's recombinant COVID-19 vaccine, originally invented by the University of Oxford, has been approved as a third dose booster vaccine in the EU.

EMA Recommends Approval of Niemann-Pick Disease Types A/B and B Therapy

May 24, 2022

EMA has recommended the marketing authorization of Xenpozyme (olipudase alfa) in the European Union.

Pandemic Science Hub Launches at University of Edinburgh

May 24, 2022

Investment has been made into a new science hub at the University of Edinburgh for the development of treatments for lung infections and future pandemics.

AstraZeneca and RQ Biotechnology Sign License Agreement for Monoclonal Antibodies

May 23, 2022

AstraZeneca has signed a license agreement with RQ Biotechnology for monoclonal antibodies to treat COVID-19.

PTC Therapeutics Receives Positive Opinion for Upstaza

May 23, 2022

PTC Therapeutics has received a positive opinion from EMA for Upstaza for the treatment of AADC deficiency.

Pfizer and BioNTech Update COVID-19 Vaccine Supply Agreement with EC

May 18, 2022

The companies have reached an agreement with the European Commission to update their COVID-19 vaccine supply agreement.

Avacta Establishes New Therapeutics Headquarters

May 16, 2022

Avacta is relocating its therapeutics headquarters to Scale Space in Imperial College’s White City Campus, London, United Kingdom.

Societal CDMO Signs Manufacturing and Supply Agreement with InfectoPharm

May 10, 2022

Societal CDMO has signed a three-year manufacturing and supply agreement with InfectoPharm for Ritalin LA in Europe.

Schott Inaugurates New Prefillable Syringe Manufacturing Facility in Germany

May 06, 2022

Schott has announced the inauguration of its new high-end polymer prefillable syringe manufacturing facility in Mülheim, Germany.